1Zou S, Dorsey KA, Notari E, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion ,2010 ;50(7) : 149,5-1504.
2Zou S, Stramer SL, Notari E, et al Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion ,2009 ;49(8) : 1609-1620.
3U. S. Food and Drug Administration. Blood and blood products, inspection of licensed and unlicensed blood banks, brokers, reference laboratories, and contractors- 7342. 0011/ FDA. Compliance program guidance manual.2012-10-01 [2013-04-10] http:// www. fda. gov/biologicsbloodvaccines/ guidancecomplianceregulatoryinformation/complianceactivitiesl enforcement/compliancepro- grams/ucm095226. htm.
4United States District Court for the District of Columbia. Amended Consent Decree of Permanent Injunction. 2003-04-15 [2012-04-12] http://www. fda. gov/ AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/ucm 170532. htm.
